Ligand Pharmaceuticals Inc (NASDAQ:LGND)

71.15
Delayed Data
As of Mar 21
 -0.50 / -0.70%
Today’s Change
45.25
Today|||52-Week Range
83.95
+6.51%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.3B

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Contact Information

Ligand Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego California 92121
P:(858) 550-7500
Investor Relations:
(858) 550-7766

Employees

Shareholders

Mutual fund holders60.52%
Individual stakeholders31.87%
Other institutional28.97%

Top Executives

Todd C. DavisChief Executive Officer & Director
Matthew Edward KorenbergPresident & Chief Operating Officer
Octavio EspinozaChief Financial Officer
Simon LatimerInvestors Relations Manager
Audrey Warfield-GrahamChief People Officer